Publication:
Current Comments on Upper Gastrointestinal System Bleeding Data from a Research Hospital

dc.authorscopusid56358309700
dc.authorscopusid7801640910
dc.contributor.authorUnal, M.
dc.contributor.authorSandikçi, S.
dc.date.accessioned2025-12-11T00:34:40Z
dc.date.issued2025
dc.departmentOndokuz Mayıs Üniversitesien_US
dc.department-temp[Unal] Mustafa, Department of Family Medicine, Ondokuz Mayis University, Medical School, Samsun, Turkey; [Sandikçi] Sunay C., Department of Internal Medicine, VKV Amerikan Hastanesi, Istanbul, Turkeyen_US
dc.description.abstractUpper gastrointestinal system (GIS) bleeding is one of the most common causes of hospitalization. This study aims to investigate the etiology of bleeding in patients admitted to Adana Numune Training and Research Hospital with the diagnosis of upper GIS bleeding. The study was conducted with 135 patients who applied for Upper GIS bleeding and underwent endoscopy between April and August 2005. This was a prospective study and all consecutive patients with upper GIS bleeding were included. Data were presented as ‘n, (%)’,’ mean ± standard deviation’. Of the patients 65.2% (n=88) were male, and the mean age was 56.7. The most common presenting symptoms were melena 44%(n=60), hematemesis 33% (n=45) and hematemesis+melena 16.3%(n=22). The most common etiologies were duodenal ulcer (35%, n=48), gastric ulcer (17%, n=23) and acute mucosal lesion (11%, n=15). Hp+ cases were 62.2% (n=84). Smoking was 28.1%(n=38), alcohol use was 13.3%(n=18). Of the patients 33% (n=45) had a history of previous Upper (GIS) bleeding, 52% (n=70) had ulcer-dyspepsia and 43% (n=58) had a history of NSAID use. Acetyl salicylic acid (ASA) was most commonly used as NSAID in 68.9%(n=40), flurbibrofen sodium in 39.6%(n=23), diclofenac in 29.3% (n=17) and multiple drugs in 39.6%(n=23). The reasons for taking ASA were cardiovascular protection in 55%(n=22).The use of NSAID’s accompanies upper GİS bleeding with ASA use is the most common. When using these drugs, their effects on upper GI bleeding should be taken into consideration. © 2025 Ondokuz Mayis Universitesi. All rights reserved.en_US
dc.identifier.doi10.52142/omujecm.42.1.3
dc.identifier.endpage13en_US
dc.identifier.issn1309-4483
dc.identifier.issn1309-5129
dc.identifier.issue1en_US
dc.identifier.scopus2-s2.0-105002324069
dc.identifier.scopusqualityQ4
dc.identifier.startpage10en_US
dc.identifier.urihttps://doi.org/10.52142/omujecm.42.1.3
dc.identifier.urihttps://hdl.handle.net/20.500.12712/37650
dc.identifier.volume42en_US
dc.language.isoenen_US
dc.publisherOndokuz Mayis Üniversitesien_US
dc.relation.ispartofJournal of Experimental and Clinical Medicine (Turkey)en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectAcetylsalicylic Aciden_US
dc.subjectCOVID-19en_US
dc.subjectNonsteroidal Anti-Inflammatory Drugen_US
dc.subjectUpper Gastrointestinal System (GIS) Bleedingen_US
dc.titleCurrent Comments on Upper Gastrointestinal System Bleeding Data from a Research Hospitalen_US
dc.typeArticleen_US
dspace.entity.typePublication

Files